Back to results
US 7,598,379 B2Granted
Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthines
AssigneePGx Health, LLC
InventorsGuoquan Wang, Jayson M. Rieger, Robert D. Thompson
Life of this patent
Estimating the term…
Abstract
The present invention provides processes for making pyridyl-linked-xanthines of formula VII, from 5,6-diamino-1H-pyrimidine-2,4-diones of formula II and acylating agents of formula VI. The xanthines are expected to be are selective antagonists of A2B adenosine receptors (ARs).
Claims10
A process for preparing a compound of formula VII:
- the process, comprising:
- (a) contacting a 5,6-diamino-1H-pyrimidine-2,4-dione of formula II:
- with an acylating agent of formula VI:
- in an aprotic solvent to produce a 1H-pryimidine-2,4-dione of formula IV:
- (b) contacting the 1H-pryimidine-2,4-dione of formula IV with a base to produce a xanthine of formula VII;
- wherein:
- X′ and X″ are each independently selected from the group consisting of Cl, Br, and I;
- R1 is (C3-8)cycloalkyl;
- and,
- R2 is hydrogen, or is selected from the group consisting of substituted or unsubstituted (C1-8)alkyl, halo(C1-8)alkyl-, (C3-8)alkenyl, (C3-8)alkenyl(C1-8)alkyl-, (C3-8)alkynyl, (C3-8)alkynyl(C1-8)alkyl-, (C1-8)alkoxy, (C3-8)cycloalkyl, (C3-8)cycloalkyl(C1-8)alkyl-, (C4-10)hererocyclyl, (C4-10)heterocyclyl(C1-8)alkyl-, (C6-10)aryl, (C6-10)aryloxy, (C6-10)aryl(C1-8)alkyl-, (C5-10)heteroaryl, and (C5-10)heteroaryl(C1-8)alkyl-.
7 more elements
Dependencies are inferred from the claim text.